Skip to main content

Table 1 Patients characteristics

From: Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases

Parameter All patients (n = 50)
Age, median (range) 62 (36 to 77)
Sex (male/female) 34/16
ECOG performance status, n (0/1) 49/1
Disease stage, n (%)  
   M0/M1 15 (30)/35(70)
   N0/N1,2 16 (32)/34 (68)
   G1/2/3 7 (15)/41(81)/2 (4)
Number of metastatic lesions (%)  
   1 15 (30)
   2–3 11 (22)
   ≥ 4 24 (48)
Lymph-node positive primary tumors, n (%) 34 (68)
Duration of metastatic disease < 12 months, n (%) 37 (74)
CEA > 20 ng/mL, n (%) 15 (30)
Synchronous metastases, n (%) 35 (70)
  1. ECOG = Eastern Cooperative Oncology Group; CEA = carcinoembryonic antigen